News

Lilly pill cuts body weight by 12.4% in trial, lagging Novo's Wegovy injection
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in ...
Lilly Pill Helps People Lose Up to 12% of Body Weight, a Bit Less Than Expected
The experimental obesity medicine is one of two that could offer alternatives to weight-loss injections within the next year ...
BioSpace31m
Lilly’s Hotly Anticipated Oral Weight Loss Drug Delivers Lukewarm Results in Phase III
Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...
Stock Movers: Intel, PTON, Ely Lilly
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Eli Lilly beats earnings for second quarter on strong GLP-1 sales, stock dives on GLP-1 pill trial results
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
Eli Lilly to sell troubled N.J. pharmaceutical plant, but says jobs are safe. Here’s why.
Eli Lilly and Company has confirmed it’s selling its 25,000-square-foot manufacturing site in Branchburg. The decision was ...
Lilly: Q2 Earnings Snapshot
Earnings, adjusted for one-time gains and costs, came to $6.31 per share. The results surpassed Wall Street expectations. The ...
The Daily Reporter15h
Eli Lilly and Co. could get $100 million in state tax credits
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...